AI-Powered Hub Mosaic: Transforming BMS's Digital Strategy

Bristol Myers Squibb and Accenture launched Mosaic, an AI-driven content hub in Mumbai, to improve patient-centric content creation for healthcare professionals. This initiative is part of BMS's $130M investment in AI strategies, with global expansion plans for 2026.

In a strategic move to enhance its digital capabilities, biopharmaceutical giant Bristol Myers Squibb (BMS) partnered with IT services firm Accenture to inaugurate Mosaic, an AI-driven content hub, in Mumbai.

This innovative facility is poised to revolutionize BMS's global commercialization approach through the rapid development of hyper-personalized content, catering specifically to healthcare professionals' needs.

With mosaic, already piloted for key brands in the US and aiming for global reach by 2026, BMS is taking significant steps forward in its $130 million investment in AI and digital marketing capabilities.

(With inputs from agencies.)